Sargent Investment Group LLC Sells 3,275 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

by · The Cerbat Gem

Sargent Investment Group LLC decreased its stake in Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 48.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,554 shares of the company’s stock after selling 3,275 shares during the period. Sargent Investment Group LLC’s holdings in Ryan Specialty were worth $236,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in RYAN. Hollencrest Capital Management bought a new stake in Ryan Specialty during the third quarter worth about $25,000. Assetmark Inc. acquired a new stake in Ryan Specialty during the 3rd quarter valued at $34,000. GAMMA Investing LLC raised its position in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after purchasing an additional 297 shares during the last quarter. Crewe Advisors LLC acquired a new position in Ryan Specialty in the second quarter worth $39,000. Finally, Signaturefd LLC grew its holdings in shares of Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after purchasing an additional 148 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.

Wall Street Analyst Weigh In

RYAN has been the subject of several research reports. Citigroup raised their price objective on shares of Ryan Specialty from $56.00 to $62.00 and gave the company a “neutral” rating in a research report on Tuesday, July 23rd. UBS Group boosted their price objective on shares of Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a research report on Tuesday, August 13th. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $65.00 to $75.00 in a research report on Tuesday, September 24th. Wells Fargo & Company boosted their target price on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. Finally, Bank of America raised their price target on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 10th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $70.33.

Get Our Latest Research Report on Ryan Specialty

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $64.69, for a total value of $2,264,150.00. Following the sale, the director now owns 19,251 shares of the company’s stock, valued at approximately $1,245,347.19. The trade was a 64.51 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Mark Stephen Katz sold 14,790 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the sale, the executive vice president now owns 12,386 shares in the company, valued at $884,236.54. The trade was a 54.42 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 94,193 shares of company stock valued at $6,208,493 in the last ninety days. 11.10% of the stock is currently owned by corporate insiders.

Ryan Specialty Stock Down 1.2 %

Ryan Specialty stock opened at $70.88 on Friday. The company’s 50 day simple moving average is $68.14 and its 200 day simple moving average is $61.66. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market capitalization of $18.56 billion, a price-to-earnings ratio of 92.05, a PEG ratio of 1.63 and a beta of 0.62. Ryan Specialty Holdings, Inc. has a fifty-two week low of $41.49 and a fifty-two week high of $73.10.

Ryan Specialty (NYSE:RYANGet Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting the consensus estimate of $0.41. The business had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty’s revenue for the quarter was up 20.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.32 EPS. As a group, sell-side analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current year.

Ryan Specialty Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be given a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.62%. Ryan Specialty’s dividend payout ratio is currently 57.14%.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

See Also